{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T12:04:48Z","timestamp":1788177888559,"version":"build-2803163510"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T00:00:00Z","timestamp":1653955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T00:00:00Z","timestamp":1653955200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006126","name":"Hospital for Sick Children","doi-asserted-by":"publisher","award":["The Campbell Chair for Immunology Research"],"award-info":[{"award-number":["The Campbell Chair for Immunology Research"]}],"id":[{"id":"10.13039\/501100006126","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006126","name":"Hospital for Sick Children","doi-asserted-by":"publisher","award":["The Campbell Chair for Immunology Research"],"award-info":[{"award-number":["The Campbell Chair for Immunology Research"]}],"id":[{"id":"10.13039\/501100006126","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006126","name":"Hospital for Sick Children","doi-asserted-by":"publisher","award":["The Campbell Chair for Immunology Research"],"award-info":[{"award-number":["The Campbell Chair for Immunology Research"]}],"id":[{"id":"10.13039\/501100006126","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006126","name":"Hospital for Sick Children","doi-asserted-by":"publisher","award":["The Campbell Chair for Immunology Research"],"award-info":[{"award-number":["The Campbell Chair for Immunology Research"]}],"id":[{"id":"10.13039\/501100006126","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006955","name":"Office of Extramural Research, National Institutes of Health","doi-asserted-by":"publisher","award":["ZIA AI001222"],"award-info":[{"award-number":["ZIA AI001222"]}],"id":[{"id":"10.13039\/100006955","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Purine nucleoside phosphorylase (PNP) is an important enzyme in the purine degradation and salvage pathway. PNP deficiency results in marked T lineage lymphopenia and severe immunodeficiency. Additionally, PNP-deficient patients and mice suffer from diverse non-infectious neurological abnormalities of unknown etiology. To further investigate the cause for these neurologic abnormalities, induced pluripotent stem cells (iPSC) from two PNP-deficient patients were differentiated into neurons. The iPSC-derived PNP-deficient neurons had significantly reduced soma and nuclei volumes. The PNP-deficient neurons demonstrated increased spontaneous and staurosporine-induced apoptosis, measured by cleaved caspase-3 expression, together with decreased mitochondrial membrane potential and increased cleaved caspase-9 expression, indicative of enhanced intrinsic apoptosis. Greater expression of tumor protein p53 was also observed in these neurons, and inhibition of p53 using pifithrin-\u03b1 prevented the apoptosis. Importantly, treatment of the iPSC-derived PNP-deficient neurons with exogenous PNP enzyme alleviated the apoptosis. Inhibition of ribonucleotide reductase (RNR) in iPSC derived from PNP-proficient neurons with hydroxyurea or with nicotinamide and trichostatin A increased the intrinsic neuronal apoptosis, implicating RNR dysfunction as the potential mechanism for the damage caused by PNP deficiency. The findings presented here establish a potential mechanism for the neurological defects observed in PNP-deficient patients and reinforce the critical role that PNP has for neuronal viability.<\/jats:p>","DOI":"10.1038\/s41598-022-10935-0","type":"journal-article","created":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T16:04:31Z","timestamp":1654013071000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Purine nucleoside phosphorylase deficiency induces p53-mediated intrinsic apoptosis in human induced pluripotent stem cell-derived neurons"],"prefix":"10.1038","volume":"12","author":[{"given":"Michael","family":"Tsui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Biro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixian","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry","family":"Dobbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi D.","family":"Notarangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyal","family":"Grunebaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,31]]},"reference":[{"issue":"6","key":"10935_CR1","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1097\/ACI.0000000000000006","volume":"13","author":"E Grunebaum","year":"2013","unstructured":"Grunebaum, E., Cohen, A. & Roifman, C. M. Recent advances in understanding and managing adenosine deaminase and purine nucleoside phosphorylase deficiencies. Curr. Opin. Allergy Clin. Immunol. 13(6), 630\u2013638. https:\/\/doi.org\/10.1097\/ACI.0000000000000006 (2013).","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"issue":"4","key":"10935_CR2","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.jaci.2011.07.039","volume":"128","author":"T Papinazath","year":"2011","unstructured":"Papinazath, T. et al. Effects of purine nucleoside phosphorylase deficiency on thymocyte development. J. Allergy Clin. Immunol. 128(4), 854-863.e1. https:\/\/doi.org\/10.1016\/j.jaci.2011.07.039 (2011).","journal-title":"J. Allergy Clin. Immunol."},{"issue":"12","key":"10935_CR3","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1084\/jem.191.12.2197","volume":"191","author":"E Arpaia","year":"2000","unstructured":"Arpaia, E. et al. Mitochondrial basis for immune deficiency. Evidence from purine nucleoside phosphorylase-deficient mice. J. Exp. Med. 191(12), 2197\u20132208. https:\/\/doi.org\/10.1084\/jem.191.12.2197 (2000).","journal-title":"J. Exp. Med."},{"issue":"6","key":"10935_CR4","doi-asserted-by":"publisher","first-page":"1804308","DOI":"10.1080\/23723556.2020.1804308","volume":"7","author":"T Davenne","year":"2020","unstructured":"Davenne, T. & Rehwinkel, J. PNP inhibitors selectively kill cancer cells lacking SAMHD1. Mol. Cell. Oncol. 7(6), 1804308. https:\/\/doi.org\/10.1080\/23723556.2020.1804308 (2020).","journal-title":"Mol. Cell. Oncol."},{"issue":"7","key":"10935_CR5","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1182\/blood-2006-03-007468","volume":"108","author":"K Balakrishnan","year":"2006","unstructured":"Balakrishnan, K., Nimmanapalli, R., Ravandi, F., Keating, M. J. & Gandhi, V. Forodesine, an inhibitor of purine nucleoside phosphorylase, induces apoptosis in chronic lymphocytic leukemia cells. Blood 108(7), 2392\u20132398. https:\/\/doi.org\/10.1182\/blood-2006-03-007468 (2006).","journal-title":"Blood"},{"issue":"4","key":"10935_CR6","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1158\/0008-5472.CAN-05-1790","volume":"66","author":"CC Ho","year":"2006","unstructured":"Ho, C. C. et al. Stalled replication induces p53 accumulation through distinct mechanisms from DNA damage checkpoint pathways. Cancer Res. 66(4), 2233\u20132241. https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-1790 (2006).","journal-title":"Cancer Res."},{"issue":"1","key":"10935_CR7","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ntt.2005.08.002","volume":"28","author":"GH Woo","year":"2006","unstructured":"Woo, G. H., Bak, E. J., Nakayama, H. & Doi, K. Molecular mechanisms of hydroxyurea(HU)-induced apoptosis in the mouse fetal brain. Neurotoxicol. Teratol. 28(1), 125\u2013134. https:\/\/doi.org\/10.1016\/j.ntt.2005.08.002 (2006).","journal-title":"Neurotoxicol. Teratol."},{"issue":"18","key":"10935_CR8","doi-asserted-by":"publisher","first-page":"8373","DOI":"10.1073\/pnas.92.18.8373","volume":"92","author":"P Benveniste","year":"1995","unstructured":"Benveniste, P. & Cohen, A. p53 expression is required for thymocyte apoptosis induced by adenosine deaminase deficiency. Proc. Natl. Acad. Sci. U.S.A. 92(18), 8373\u20138377. https:\/\/doi.org\/10.1073\/pnas.92.18.8373 (1995).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"10935_CR9","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/sj.bmt.1703100","volume":"28","author":"CF Classen","year":"2001","unstructured":"Classen, C. F. et al. Successful HLA-identical bone marrow transplantation in a patient with PNP deficiency using busulfan and fludarabine for conditioning. Bone Marrow Transplant. 28(1), 93\u201396. https:\/\/doi.org\/10.1038\/sj.bmt.1703100 (2001).","journal-title":"Bone Marrow Transplant."},{"issue":"6","key":"10935_CR10","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1177\/0883073807302617","volume":"22","author":"F Ozkinay","year":"2007","unstructured":"Ozkinay, F. et al. Purine nucleoside phosphorylase deficiency in a patient with spastic paraplegia and recurrent infections. J. Child Neurol. 22(6), 741\u2013743. https:\/\/doi.org\/10.1177\/0883073807302617 (2007).","journal-title":"J. Child Neurol."},{"issue":"3","key":"10935_CR11","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1203\/01.PDR.0000111286.23110.F8","volume":"55","author":"Y Dror","year":"2004","unstructured":"Dror, Y. et al. Purine nucleoside phosphorylase deficiency associated with a dysplastic marrow morphology. Pediatr. Res. 55(3), 472\u2013477. https:\/\/doi.org\/10.1203\/01.PDR.0000111286.23110.F8 (2004).","journal-title":"Pediatr. Res."},{"issue":"2","key":"10935_CR12","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.nbd.2012.04.001","volume":"47","author":"A Mansouri","year":"2012","unstructured":"Mansouri, A. et al. Cerebellar abnormalities in purine nucleoside phosphorylase deficient mice. Neurobiol. Dis. 47(2), 201\u2013209. https:\/\/doi.org\/10.1016\/j.nbd.2012.04.001 (2012).","journal-title":"Neurobiol. Dis."},{"issue":"2","key":"10935_CR13","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/0012-1606(79)90315-4","volume":"69","author":"CT Theisen","year":"1979","unstructured":"Theisen, C. T. Effects of hydroxyurea during final neuronal DNA synthesis in dorsal root ganglia of rats. Dev Biol. 69(2), 612\u2013626. https:\/\/doi.org\/10.1016\/0012-1606(79)90315-4 (1979).","journal-title":"Dev Biol."},{"issue":"4","key":"10935_CR14","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s12640-016-9649-x","volume":"30","author":"J Mart\u00ed","year":"2016","unstructured":"Mart\u00ed, J., Santa-Cruz, M. C., Serra, R. & Herv\u00e1s, J. P. Hydroxyurea treatment and development of the rat cerebellum: Effects on the neurogenetic profiles and settled patterns of purkinje cells and deep cerebellar nuclei neurons. Neurotox. Res. 30(4), 563\u2013580. https:\/\/doi.org\/10.1007\/s12640-016-9649-x (2016).","journal-title":"Neurotox. Res."},{"key":"10935_CR15","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3389\/fnmol.2016.00078","volume":"9","author":"S Barral","year":"2016","unstructured":"Barral, S. & Kurian, M. A. Utility of induced pluripotent stem cells for the study and treatment of genetic diseases: Focus on childhood neurological disorders. Front. Mol. Neurosci. 9, 78. https:\/\/doi.org\/10.3389\/fnmol.2016.00078 (2016).","journal-title":"Front. Mol. Neurosci."},{"issue":"1","key":"10935_CR16","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/s41398-019-0517-3","volume":"9","author":"LM Grunwald","year":"2019","unstructured":"Grunwald, L. M. et al. Comparative characterization of human induced pluripotent stem cells, hiPSC) derived from patients with schizophrenia and autism. Transl. Psychiatry 9(1), 179. https:\/\/doi.org\/10.1038\/s41398-019-0517-3 (2019).","journal-title":"Transl. Psychiatry"},{"issue":"3","key":"10935_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0118771","volume":"10","author":"Y Sun","year":"2015","unstructured":"Sun, Y. et al. Properties of neurons derived from induced pluripotent stem cells of Gaucher disease type 2 patient fibroblasts: Potential role in neuropathology. PLoS ONE 10(3), e0118771. https:\/\/doi.org\/10.1371\/journal.pone.0118771 (2015).","journal-title":"PLoS ONE"},{"issue":"2","key":"10935_CR18","doi-asserted-by":"publisher","first-page":"49","DOI":"10.14785\/lymphosign-2018-0003","volume":"5","author":"M Tsui","year":"2018","unstructured":"Tsui, M., Biro, J., Chan, J., Min, W. & Grunebaum, E. Use of induced pluripotent stem cells to investigate the effects of purine nucleoside phosphorylase deficiency on neuronal development. LymphoSign J 5(2), 49\u201356. https:\/\/doi.org\/10.14785\/lymphosign-2018-0003 (2018).","journal-title":"LymphoSign J"},{"issue":"1","key":"10935_CR19","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1038\/s41467-019-11214-9","volume":"10","author":"G Chen","year":"2019","unstructured":"Chen, G. et al. Acetylation regulates ribonucleotide reductase activity and cancer cell growth. Nat. Commun. 10(1), 3213. https:\/\/doi.org\/10.1038\/s41467-019-11214-9 (2019).","journal-title":"Nat. Commun."},{"issue":"4","key":"10935_CR20","first-page":"763","volume":"51","author":"MR Aust","year":"1992","unstructured":"Aust, M. R., Andrews, L. G., Barrett, M. J., Norby-Slycord, C. J. & Markert, M. L. Molecular analysis of mutations in a patient with purine nucleoside phosphorylase deficiency. Am. J. Hum. Genet. 51(4), 763\u2013772 (1992).","journal-title":"Am. J. Hum. Genet."},{"issue":"6","key":"10935_CR21","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1034\/j.1399-0004.2001.590608.x","volume":"59","author":"I Dalal","year":"2001","unstructured":"Dalal, I., Grunebaum, E., Cohen, A. & Roifman, C. M. Two novel mutations in a purine nucleoside phosphorylase, PNP)-deficient patient. Clin. Genet. 59(6), 430\u2013437. https:\/\/doi.org\/10.1034\/j.1399-0004.2001.590608.x (2001).","journal-title":"Clin. Genet."},{"issue":"6","key":"10935_CR22","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1016\/j.jaci.2010.11.008","volume":"127","author":"IM Pessach","year":"2011","unstructured":"Pessach, I. M. et al. Induced pluripotent stem cells: A novel frontier in the study of human primary immunodeficiencies. J. Allergy Clin. Immunol. 127(6), 1400\u20137.e4. https:\/\/doi.org\/10.1016\/j.jaci.2010.11.008 (2011).","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10935_CR23","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.cellimm.2006.07.003","volume":"240","author":"A Toro","year":"2006","unstructured":"Toro, A., Paiva, M., Ackerley, C. & Grunebaum, E. Intracellular delivery of purine nucleoside phosphorylase, PNP) fused to protein transduction domain corrects PNP deficiency in vitro. Cell. Immunol. 240(2), 107\u2013115. https:\/\/doi.org\/10.1016\/j.cellimm.2006.07.003 (2006).","journal-title":"Cell. Immunol."},{"issue":"10","key":"10935_CR24","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1093\/jnen\/60.10.984","volume":"60","author":"I Bl\u00fcmcke","year":"2001","unstructured":"Bl\u00fcmcke, I. et al. Distinct expression pattern of microtubule-associated protein-2 in human oligodendrogliomas and glial precursor cells. J. Neuropathol. Exp. Neurol. 60(10), 984\u2013993. https:\/\/doi.org\/10.1093\/jnen\/60.10.984 (2001).","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"10","key":"10935_CR25","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1172\/JCI25052","volume":"116","author":"A Toro","year":"2006","unstructured":"Toro, A. & Grunebaum, E. TAT-mediated intracellular delivery of purine nucleoside phosphorylase corrects its deficiency in mice. J. Clin. Investig. 116(10), 2717\u20132726. https:\/\/doi.org\/10.1172\/JCI25052 (2006).","journal-title":"J. Clin. Investig."},{"key":"10935_CR26","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.3389\/fimmu.2020.01257","volume":"11","author":"E Grunebaum","year":"2020","unstructured":"Grunebaum, E., Campbell, N., Leon-Ponte, M., Xu, X. & Chapdelaine, H. Partial purine nucleoside phosphorylase deficiency helps determine minimal activity required for immune and neurological development. Front. Immunol. 11, 1257. https:\/\/doi.org\/10.3389\/fimmu.2020.01257 (2020).","journal-title":"Front. Immunol."},{"issue":"8","key":"10935_CR27","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1182\/blood-2009-02-207654","volume":"114","author":"R Alonso","year":"2009","unstructured":"Alonso, R. et al. Forodesine has high antitumor activity in chronic lymphocytic leukemia and activates p53-independent mitochondrial apoptosis by induction of p73 and BIM. Blood 114(8), 1563\u20131575. https:\/\/doi.org\/10.1182\/blood-2009-02-207654 (2009).","journal-title":"Blood"},{"issue":"3","key":"10935_CR28","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1053\/jhep.2001.26749","volume":"34","author":"TU Krohne","year":"2001","unstructured":"Krohne, T. U. et al. Mechanisms of cell death induced by suicide genes encoding purine nucleoside phosphorylase and thymidine kinase in human hepatocellular carcinoma cells in vitro. Hepatology 34(3), 511\u2013518. https:\/\/doi.org\/10.1053\/jhep.2001.26749 (2001).","journal-title":"Hepatology"},{"issue":"6773","key":"10935_CR29","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/35003506","volume":"404","author":"H Tanaka","year":"2000","unstructured":"Tanaka, H. et al. A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage. Nature 404(6773), 42\u201349. https:\/\/doi.org\/10.1038\/35003506 (2000).","journal-title":"Nature"},{"issue":"5","key":"10935_CR30","first-page":"980","volume":"63","author":"L Xue","year":"2003","unstructured":"Xue, L. et al. Wild-type p53 regulates human ribonucleotide reductase by protein-protein interaction with p53R2 as well as hRRM2 subunits. Can. Res. 63(5), 980\u2013986 (2003).","journal-title":"Can. Res."},{"issue":"22","key":"10935_CR31","first-page":"8256","volume":"61","author":"T Yamaguchi","year":"2001","unstructured":"Yamaguchi, T. et al. p53R2-dependent pathway for DNA synthesis in a p53-regulated cell cycle checkpoint. Can. Res. 61(22), 8256\u20138262 (2001).","journal-title":"Can. Res."},{"issue":"4","key":"10935_CR32","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.molcel.2010.01.021","volume":"37","author":"E Petermann","year":"2010","unstructured":"Petermann, E., Orta, M. L., Issaeva, N., Schultz, N. & Helleday, T. Hydroxyurea-stalled replication forks become progressively inactivated and require two different RAD51-mediated pathways for restart and repair. Mol. Cell 37(4), 492\u2013502. https:\/\/doi.org\/10.1016\/j.molcel.2010.01.021 (2010).","journal-title":"Mol. Cell"},{"issue":"3","key":"10935_CR33","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.neuron.2017.09.055","volume":"96","author":"T Misgeld","year":"2017","unstructured":"Misgeld, T. & Schwarz, T. L. Mitostasis in neurons: Maintaining mitochondria in an extended cellular architecture. Neuron 96(3), 651\u2013666. https:\/\/doi.org\/10.1016\/j.neuron.2017.09.055 (2017).","journal-title":"Neuron"},{"key":"10935_CR34","doi-asserted-by":"publisher","first-page":"3619274","DOI":"10.1155\/2016\/3619274","volume":"2016","author":"L Narciso","year":"2016","unstructured":"Narciso, L. et al. The response to oxidative DNA damage in neurons: Mechanisms and disease. Neural Plast. 2016, 3619274. https:\/\/doi.org\/10.1155\/2016\/3619274 (2016).","journal-title":"Neural Plast."},{"key":"10935_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.748519","volume":"12","author":"M Tsui","year":"2021","unstructured":"Tsui, M. et al. The use of induced pluripotent stem cells to study the effects of adenosine deaminase deficiency on human neutrophil development. Front. Immunol. 12, 748519. https:\/\/doi.org\/10.3389\/fimmu.2021.748519 (2021).","journal-title":"Front. Immunol."},{"issue":"1","key":"10935_CR36","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1002\/(SICI)1099-1557(200001\/02)9:1<49::AID-PDS465>3.0.CO;2-C","volume":"9","author":"WF McCarthy","year":"2000","unstructured":"McCarthy, W. F., Gable, J., Lawrence, J. & Thompson, M. AIDS Research Consortium of Atlanta ASD Investigators. A retrospective study to determine if hydroxyurea augmentation of antiretroviral drug regimens that contain ddI and\/or d4T increases the risk of developing peripheral neuropathy in HIV-1 infected individuals. Pharmacoepidemiol. Drug Saf. 9(1), 49\u201353 (2000).","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"14","key":"10935_CR37","doi-asserted-by":"publisher","first-page":"3861","DOI":"10.1093\/emboj\/20.14.3861","volume":"20","author":"Y Saintigny","year":"2001","unstructured":"Saintigny, Y. et al. Characterization of homologous recombination induced by replication inhibition in mammalian cells. EMBO J. 20(14), 3861\u20133870. https:\/\/doi.org\/10.1093\/emboj\/20.14.3861 (2001).","journal-title":"EMBO J."},{"issue":"5","key":"10935_CR38","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1007\/s10875-021-01003-9","volume":"41","author":"A Eichinger","year":"2021","unstructured":"Eichinger, A. et al. Upfront enzyme replacement via erythrocyte transfusions for PNP deficiency. J. Clin. Immunol. 41(5), 1112\u20131115. https:\/\/doi.org\/10.1007\/s10875-021-01003-9 (2021).","journal-title":"J. Clin. Immunol."},{"issue":"2","key":"10935_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0118020","volume":"10","author":"HE Wheeler","year":"2015","unstructured":"Wheeler, H. E., Wing, C., Delaney, S. M., Komatsu, M. & Dolan, M. E. Modeling chemotherapeutic neurotoxicity with human induced pluripotent stem cell-derived neuronal cells. PLoS ONE 10(2), e0118020. https:\/\/doi.org\/10.1371\/journal.pone.0118020 (2015).","journal-title":"PLoS ONE"},{"issue":"5","key":"10935_CR40","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1038\/mp.2017.56","volume":"23","author":"N Gunhanlar","year":"2018","unstructured":"Gunhanlar, N. et al. A simplified protocol for differentiation of electrophysiologically mature neuronal networks from human induced pluripotent stem cells. Mol. Psychiatry 23(5), 1336\u20131344. https:\/\/doi.org\/10.1038\/mp.2017.56 (2018).","journal-title":"Mol. Psychiatry"},{"key":"10935_CR41","doi-asserted-by":"publisher","first-page":"55702","DOI":"10.3791\/55702","volume":"124","author":"F Pistollato","year":"2017","unstructured":"Pistollato, F., Canovas-Jorda, D., Zagoura, D. & Price, A. Protocol for the differentiation of human induced pluripotent stem cells into mixed cultures of neurons and glia for neurotoxicity testing. J. Vis. Exp. 124, 55702. https:\/\/doi.org\/10.3791\/55702 (2017).","journal-title":"J. Vis. Exp."},{"issue":"13","key":"10935_CR42","doi-asserted-by":"publisher","first-page":"489","DOI":"10.3389\/fncel.2019.00489.PMID:31787882;PMCID:PMC6854036","volume":"7","author":"M Gautam","year":"2019","unstructured":"Gautam, M., Xie, E. F., Kocak, N. & Ozdinler, P. H. Mitoautophagy: A unique self-destructive path mitochondria of upper motor neurons with TDP-43 pathology take, very early in ALS. Front Cell Neurosci. 7(13), 489. https:\/\/doi.org\/10.3389\/fncel.2019.00489.PMID:31787882;PMCID:PMC6854036 (2019).","journal-title":"Front Cell Neurosci."},{"key":"10935_CR43","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1146\/annurev.neuro.051508.135600","volume":"32","author":"A Kriegstein","year":"2009","unstructured":"Kriegstein, A. & Alvarez-Buylla, A. The glial nature of embryonic and adult neural stem cells. Annu. Rev. Neurosci. 32, 149\u2013184. https:\/\/doi.org\/10.1146\/annurev.neuro.051508.135600 (2009).","journal-title":"Annu. Rev. Neurosci."},{"key":"10935_CR44","doi-asserted-by":"publisher","first-page":"9232","DOI":"10.1038\/srep09232","volume":"5","author":"S Wang","year":"2015","unstructured":"Wang, S. et al. Differentiation of human induced pluripotent stem cells to mature functional Purkinje neurons. Sci. Rep. 5, 9232. https:\/\/doi.org\/10.1038\/srep09232 (2015).","journal-title":"Sci. Rep."},{"key":"10935_CR45","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3389\/fncel.2018.00239","volume":"32","author":"F Bianchi","year":"2018","unstructured":"Bianchi, F. et al. Rapid and efficient differentiation of functional motor neurons from human iPSC for neural injury modelling. Stem Cell Res. 32, 126\u2013134. https:\/\/doi.org\/10.1016\/j.scr.2018.09.006 (2018).","journal-title":"Stem Cell Res."},{"key":"10935_CR46","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3389\/fncel.2018.00239","volume":"12","author":"W Zheng","year":"2018","unstructured":"Zheng, W. et al. Differentiation of glial cells from hiPSCs: Potential applications in neurological diseases and cell replacement therapy. Front. Cell. Neurosci. 12, 239. https:\/\/doi.org\/10.3389\/fncel.2018.00239 (2018).","journal-title":"Front. Cell. Neurosci."},{"issue":"1","key":"10935_CR47","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2174\/157015909787602823","volume":"7","author":"B Uttara","year":"2009","unstructured":"Uttara, B., Singh, A. V., Zamboni, P. & Mahajan, R. T. Oxidative stress and neurodegenerative diseases: A review of upstream and downstream antioxidant therapeutic options. Curr. Neuropharmacol. 7(1), 65\u201374. https:\/\/doi.org\/10.2174\/157015909787602823 (2009).","journal-title":"Curr. Neuropharmacol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-10935-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-10935-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-10935-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T03:52:16Z","timestamp":1669348336000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-10935-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,31]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["10935"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-10935-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,31]]},"assertion":[{"value":"11 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9084"}}